Home > 연구개발 >
Pipeline
R&D CODE
CATEGORY
ONGOING
HL007
Hypertension / Hyperlipidemia(Combination Drug)
Patent issued & NDA submission in Korea,
Patent application & IND approval in US
HL008
Hypertension(Combination drug)
Patent issued & Phase I in Korea,
Patent application & Pre-IND in US
HL009
Atopy disease(Vit B12 Liposomal Gel)
Patent issued & Phase 2 in Korea,
Patent application & Phase 2 in US
HL010
Diabetes Mellitus & Oncology(Single drug, NCE)
Patent application, Lead optimization
HL018
Diabetes Mellitus(Single drug, 2nd generation)
Patent application & NDA submission in Korea
HL030
Antiplatelet agents(Combination drug)
Patent application & IND approval in Korea
HL031
Oral Interferon agents
Patent issued
HL032
Oral hGH
Patent application & IND approval in Korea
HL036
Anti-TNF alpha
Patent application & Lead optimization
HL040
Hypertension / Hyperlipidemia(Combination drug)
Patent application & Phase 1 in Korea,
IND preparation in US
HL051
Hypertension(Combination drug)
Patent issued & IND approval in Korea
HL053
Hypertension/Hyperlipidemia(Combination drug)
Patent application & IND approval in Korea
HL092
Hyperlipidemia/Hypertension (Combination drug)
Formulation
HL143
Mutant Interferon alpha
Patent issued in Korea
Patent issued & Phase 2 in US
HL156
AMPK activators
Lead optimization
HL161
Anti-FcRn mAb for Autoimmune Diseases
Lead optimization
HL170
Hyperlipidemia/Hypertention(Combination drug)
Formulation
